L.6. Promoting integrated and coherent systems of scientific evidence-based public health responses to drug use Chair: Informal discussions this morning on a number of resolutions. We will continue until 5:45pm, so that I can discuss with the sponsors during the last 15 minutes. Tomorrow morning, we will suspend our work during the CND’s votes on …
Side event: A decade of drug policy and human rights: Gaps, achievements and paths forward
Swiss Ambassador for Global health. It is a pleasure for me to be here with you and welcome you to this side event organised by Switzerland and cosponsored by a number of Member States and other stakeholders. We continue to promote human rights and a public health centred approach to drug policy. This event comes …
Plenary – Monday morning session
Item 1. Election of Officers Chair: Chair: It’s a great honour to welcome you to the 69th session of the CND and for me to chair the CND. It’s the first time that Armenia holds the chair over CND and I would like to thank you for the support and trust. No country can tackle the …
The Next Generation of Care: Youth-Centered Innovations to Renew and Strengthen Health Systems
The 69th session of the Commission on Narcotic Drugs (CND), held in March 2026 in Vienna, took place nearly ten years after the 2016 UNGASS on drugs, which carried the slogan “A better tomorrow for today’s youth.” This side event by Youth RISE and the Global Commission on Drug Policy (GCDP) brought this commitment under …
Reconvened 68th session of the CND – 5 December 2025
Chair CND: Yesterday we considered the consolidated budget for 2026-2027. I understand that there have been informal consultations during which the draft resolution was amended. The amended text of the draft resolution after these informal consultations was circulated via special message on 22nd November and agreed upon by silence procedure on 25th November. May I …
SIDE EVENT: Interactive dialogue on the WHO ECDD recommendations following the critical review of the coca leaf
Dr Deus Mubangizi, Director, Health Products Policy and Standards Department, World Health Organization. It will be important to understand the process we went through. For critical reviews, if we need more expertise, we issue a call. In this case, because of the nature of the request, we issued an open call for experts. A number …